Target intelligence / Profile preview

Immunity-related GTPase Q (IRGQ)

Target
IRGQ
Molecular classification
Large GTPase, Dynamin-like protein, Interferon-inducible GTPase, Immunity-related GTPase (IRG) family
01

Overview

Immunity-related GTPase Q (IRGQ) is a member of the IRG family of interferon-inducible, dynamin-like large GTPases critical for cell-autonomous defense against intracellular pathogens. IRG proteins are rapidly induced by interferon-gamma (IFNγ) and localize to pathogen-containing vacuoles within cells, promoting the rupture of these compartments and exposing pathogens to cytosolic immune effectors. About 20 effector IRGs—including IRGQ—are regulated by three membrane-bound IRG family members and recognize specific membrane signals, leading to targeted elimination of intracellular bacteria and protozoa such as *Toxoplasma gondii* and *Chlamydia trachomatis*. IRGQ itself functions as part of a coordinated defense network, with its activity linked to GTP binding and hydrolysis, membrane targeting, and the disruption of pathogen-containing vacuoles. While IRGs are not currently targeted by drugs, their central role in antimicrobial immunity makes them an area of interest for research into resistance and immune system modulation[2].

Other names
IIGP2IrgqImmunity-related GTPase QIRGQ GTPase
02

Biological functions

Immune responseCell-autonomous immunityPathogen targeting and vacuole disruptionSignal transduction (related to GTPase activity in immunity)
03

Disease associations

Infection (major role in host resistance to intracellular bacterial and protozoal pathogens)Flammation (regulation of immune cell response; IRGs are associated with enhanced inflammatory defense)

Beyond the preview

Go deeper on Immunity-related GTPase Q (IRGQ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunity-related GTPase Q (IRGQ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call